Ewha Womans University Medical Center
Ewha Womans University Medical Center
Republic of Korea, Seoul
Paik Nam-sun
47 years of experience
accreditations :
Clinic is certified :
| Republic of Korea | Turkey | Austria | |
| Symptomatic treatment | - | from $300 | from $700 |
No hidden fees – just official clinic prices. Pay at the clinic for Polycystic kidney disease treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Polycystic kidney disease treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Polycystic kidney disease treatment journey.
Featured twice on EBS 'Medical Experts' for prostate and urinary stone disorders – Dr. Lee brings elite urology expertise to polycystic kidney disease cases.
The doctor is a leading breast cancer specialist in South Korea and is recognized among the world’s top 100 gastric and breast cancer surgeons. The doctor pioneered breast conserving surgery in South Korea in 1986 and invented a unique stomach cancer surgery that minimizes the risk of gastroesophageal reflux disease. The doctor currently heads the Cancer Center for Women at Ewha Womans University Medical Center and has previously served as President of Konkuk University Hospital and Director of Korea Cancer Center Hospital. The doctor is also an active researcher in breast cancer diagnosis and management.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
Tolvaptan is available in South Korea for treating Autosomal Dominant Polycystic Kidney Disease (ADPKD). The Ministry of Food and Drug Safety approved it in 2015. National Health Insurance has covered this medication since 2019 for specific adult patients with rapid disease progression.
Bookimed Expert Insight: South Korea is a leader in medical digitalization. Centers like Seoul National University Bundang Hospital use the BESTcare system to track drug titration. This digital monitoring is vital for Tolvaptan. It ensures precise dosing and safety for patients with fluctuating renal function.
Patient Consensus: While international discussions often focus on high costs, patients in Korea benefit from national insurance coverage. Many emphasize the need for strict adherence to the monthly blood test schedule required by local regulations.
Asan Medical Center, Seoul National University Hospital, and Severance Hospital are the premier facilities for polycystic kidney disease and transplants. These JCI-accredited institutions report transplant success rates up to 98%. They utilize advanced robotic systems and multidisciplinary teams for complex inherited conditions.
Bookimed Expert Insight: Patient volume is a primary indicator of quality in Seoul. Asan Medical Center treats 11,800 outpatients daily and manages 45% of Korea's heart transplants. This high volume across all organ categories ensures surgeons maintain peak proficiency for complex multi-organ cases often seen in advanced polycystic kidney disease.
Patient Consensus: Patients emphasize the need to start the Korean Organ Transplantation Registry paperwork early. Those who chose Asan Medical Center specifically praised the experienced surgeons and dedicated support for international patients.
South Korea offers sophisticated non-surgical management for polycystic kidney disease through Tolvaptan medication and clinical research. Major Seoul-based medical centers provide access to phase 4 pharmacological trials and innovative arterial stem cell therapies. Most protocols focus on slowing cyst growth and preserving organ function.
Bookimed Expert Insight: Korea is a leader in digitalized medicine which significantly improves safety during longitudinal PKD care. Seoul National University Bundang Hospital was the first digital hospital globally. Their BESTcare system uses AI to analyze EHRs and track progression. This digital focus helps doctors identify small changes in cyst volume faster than traditional manual reviews.
Patient Consensus: Patients note it's important that international clinics in Seoul provide personalized coordination. Many find that having experts handle translations and appointments makes specialized pharmacological therapy much easier to manage.